ReviewJournal for immunotherapy of cancer2021

COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies.

Jason D Goldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.